NCT01372579 2019-06-07
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
Northwestern University
Phase 2 Unknown
Northwestern University
Northwestern University
Institute of Cancer Research, United Kingdom
Alliance for Clinical Trials in Oncology
Salah Azaïz Cancer Institute
National Taiwan University Hospital
Wales Cancer Trials Unit